Keyword
Why the yellow MatsuKiyo signage in Ginza, Shinjuku and Shibuya makes Matsukiyo Cocokara — formed from the 2021 Matsumoto Kiyoshi + Cocokara Fine merger — Japan's most tourist-channel-exposed drugstore, and how that differs from Welcia and Tsuruha's suburban dispensing model.
Inside the Hokkaido-born ~2,500-store federation — and the 2024 Welcia merger, prompted by Seth Fischer's Oasis Management, that will reshape Japan's distribution channels for foreign cosmetics, OTC and food brands.
How a single Ibaraki pharmacy became Asia's drugstore king-in-waiting — and why the 2027 Welcia-Tsuruha integration reshapes Japan's $80B pharmacy market.
Why Japan's #2 non-life insurer's controversial Bigmotor episode exposed Japan's insurance-distribution conflicts, and how SOMPO Care plus SOMPO International make it more than a domestic insurer.
The maker of Salonpas, the world's number-one OTC pain-relief patch, built on mastery of delivering medicine through the skin
The Japanese drugmaker that co-developed Leqembi, among the first treatments shown to slow Alzheimer's disease
A Japanese antiviral specialist behind the flu drug Xofluza and COVID antiviral Xocova — including the first oral COVID post-exposure prevention pill
Japan's most valuable pharmaceutical company, inventor of antibody blockbusters and majority-owned by Roche since 2002
How Fujifilm turned the death of photographic film into record revenues in healthcare, biologics, and high-tech materials
The number-one baby-bottle and nursing brand in Japan and a leading baby-care brand across Asia
The world's third-largest personal-hygiene maker, whose MamyPoko diapers and hygiene products are household staples across Asia
The world leader in coronary guidewires — the ultra-fine wires that guide catheters through blood vessels in life-saving heart procedures
